Accelerating Drug Development: Antiviral Therapies for Emerging Viruses as a Model

Academic Article

Abstract

  • © 2017 by Annual Reviews. All rights reserved. Drug discovery and development is a lengthy and expensive process. Although no one, simple, single solution can significantly accelerate this process, steps can be taken to avoid unnecessary delays. Using the development of antiviral therapies as a model, we describe options for acceleration that cover target selection, assay development and high-throughput screening, hit confirmation, lead identification and development, animal model evaluations, toxicity studies, regulatory issues, and the general drug discovery and development infrastructure. Together, these steps could result in accelerated timelines for bringing antiviral therapies to market so they can treat emerging infections and reduce human suffering.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Everts M; Cihlar T; Bostwick JR; Whitley RJ
  • Start Page

  • 155
  • End Page

  • 169
  • Volume

  • 57